Tissue Regenix
York · Founded 2006
About Tissue Regenix
Tissue Regenix commercializes innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. Tissue Regenix was founded in May 2006, to commercialize innovative technologies in regenerative medicine.
Company Facts
- Founded: 2006
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $29.7M
- Funding stage: IPO
- Last round: Post-IPO Debt (Dec 2025)
- Ticker: lse:TRX
- Website: tissueregenix.com
- Phone: +44 1904 567609
Industries & Categories
Health Care, Health Diagnostics, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/tissue-regenix-23992 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.